Arsphenamine - Explore the Science & Experts | ideXlab


Scan Science and Technology

Contact Leading Edge Experts & Companies

Arsphenamine

The Experts below are selected from a list of 1179 Experts worldwide ranked by ideXlab platform

Arsphenamine – Free Register to Access Experts & Abstracts

New York – One of the best experts on this subject based on the ideXlab platform.

  • SEVERE BONE-MARROW DEPRESSION FOLLOWING Arsphenamine; REPORT OF TWO CASES WITH RECOVERY *
    , 2016
    Co-Authors: Abraham Lieberson, Arthur Weiss, New York

    Abstract:

    T H E authors delayed reporting the following two cases of Arsphenamine bone-marrow depression for several years in order to make certain of the permanency of the recovery which occurred in both cases. The blood dys-pasias occasionally caused by Arsphenamine have been reported in the litera-ture mainly under the headings of their outstanding clinical manifestations, such as granulocytopenia, agranulocytosis, thrombocytopenia, or aplastic anemia. A study of these reports and of the two patients who were fol-lowed carefully on the wards of Beth Israel Hospital has confirmed our belief that most cases may best be considered as early or late instances of the same toxic process which in its severest form causes complete aplasia of the bone-marrow

    Free Register to Access Article

Abraham Lieberson – One of the best experts on this subject based on the ideXlab platform.

  • SEVERE BONE-MARROW DEPRESSION FOLLOWING Arsphenamine; REPORT OF TWO CASES WITH RECOVERY *
    , 2016
    Co-Authors: Abraham Lieberson, Arthur Weiss, New York

    Abstract:

    T H E authors delayed reporting the following two cases of Arsphenamine bone-marrow depression for several years in order to make certain of the permanency of the recovery which occurred in both cases. The blood dys-pasias occasionally caused by Arsphenamine have been reported in the litera-ture mainly under the headings of their outstanding clinical manifestations, such as granulocytopenia, agranulocytosis, thrombocytopenia, or aplastic anemia. A study of these reports and of the two patients who were fol-lowed carefully on the wards of Beth Israel Hospital has confirmed our belief that most cases may best be considered as early or late instances of the same toxic process which in its severest form causes complete aplasia of the bone-marrow

    Free Register to Access Article

Arthur Weiss – One of the best experts on this subject based on the ideXlab platform.

  • SEVERE BONE-MARROW DEPRESSION FOLLOWING Arsphenamine; REPORT OF TWO CASES WITH RECOVERY *
    , 2016
    Co-Authors: Abraham Lieberson, Arthur Weiss, New York

    Abstract:

    T H E authors delayed reporting the following two cases of Arsphenamine bone-marrow depression for several years in order to make certain of the permanency of the recovery which occurred in both cases. The blood dys-pasias occasionally caused by Arsphenamine have been reported in the litera-ture mainly under the headings of their outstanding clinical manifestations, such as granulocytopenia, agranulocytosis, thrombocytopenia, or aplastic anemia. A study of these reports and of the two patients who were fol-lowed carefully on the wards of Beth Israel Hospital has confirmed our belief that most cases may best be considered as early or late instances of the same toxic process which in its severest form causes complete aplasia of the bone-marrow

    Free Register to Access Article